SV Life Sciences raises $523 million for fifth fund

SV Life Sciences said that it has raised more than $523 million for its fifth international life sciences fund which will focus on providing start-up, early stage and expansion capital to life science companies in the US and Europe.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States